Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: John F Beule who wrote (724)	12/4/1998 3:04:00 PM
From: Anthony Wong	Respond to of 2539

Monsanto Co. Receives $2.0 Bln Credit Facility From Citibank Bloomberg News December 4, 1998, 2:07 p.m. ET Princeton, New Jersey, Dec. 4 (Bloomberg) - Following are details of a new credit facility according to a SC 14D1/A filed with the Securities and Exchange Commission on Nov. 24, 1998: Borrower: Monsanto Co. Administrative Agent: Citibank Arranger: Salomon Smith Barney Co-Syndication Agents: Bank of America & Commerzbank AG Facility Amount: $2 Billion Loan Type: Revolver Effective: Nov. 18, 1998 Maturity Nov. 17, 1999 Purpose: Finance acquisition of Dekalb Genetics Inc. Current Base: London Interbank Offered Rate Spread Range: 23.50 to 100.00 Basis Points Comp Bid Option: Yes Facility Fee: 6.50 to 25.00 Basis Points Monsanto Company, a global life sciences company, applies biological science to an integrated system of agriculture, food, and human health. The Company and its subsidiaries manufacture and sell agricultural products, nutrition and consumer products, pharmecuticals, and other products. Monsanto operates manufacturing, research, sales, and administrative facilities worldwide. The borrower is required to maintain certain financial covenants as fully described in the agreement. For more details on the above issue type TKL from the yellow Corporate Key. For further information, contact Bloomberg's Corporate Loan Group at (609)279-3500 or e-mail LOANS1@Bloomberg.Net. --By Jason Coulter in the Corporate Loan Group (609)279-3434 tas